July 17, 2020

On Sept 15, 2020, VDP will extend the non-preferred prior authorization duration for macrolides from 30 days to 90 days for people with a diagnosis of Gastroparesis, Cerebral Palsy Gastroparesis, or GERD Gastrostomy complications. This will accommodate longer-term prescribing for such conditions.

MCOs are required to comply with this PDL prior authorization criteria, including duration.

HHSC will update the Preferred Drug List and Preferred Drug List Criteria Guide (PDF) in Sept. to reflect this change.

Tags: 
PDL